Allotment of 11.73 lakh equity shares on warrant conversion

Warrants ConvertedFund Raising View source PDF Explain this filing

SHUKRAPHAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+10.6%Reaction day

₹47.00

prior close

₹47.37

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%+10.0% vs market

Pharmaceuticals peers, median of 172sector+0.3%+10.3% vs sector

On the reaction day the stock moved 10.0 pts more than Nifty Microcap 250 and 10.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+3.4

15m

+4.9

30m

+6.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+10.6+0.6+10.0+0.3+10.3

Next day

+10.6+1.3+9.3+0.2+10.3

+13.1+1.7+11.4+0.8+12.3

+15.2+2.2+13.0+1.1+14.1

+21.5+2.1+19.4+0.6+20.8

+14.9+1.9+13.0+0.8+14.1

+18.0-1.3+19.3-1.1+19.1

15d

+19.1+1.3+17.8+0.8+18.4

+51.1-0.8+51.9-2.2+53.3

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board allotted 11,73,000 equity shares (Re.1 face value) to promoter Navkar Surgical Gujarat Ltd upon conversion of warrants at Rs.35.56 per share. Company received Rs.3.13 crore as balance 75 percent exercise price. Promoter holding rises from 11.78 percent to 11.93 percent. Paid-up equity capital increases to Rs.44.08 crore. 17.35 lakh warrants still outstanding for conversion within 18 months.

Likely market impact

Minor equity dilution. Promoter converted warrants, showing confidence. 17.35 lakh more warrants pending conversion may add supply later.